Ranking vaccines : a prioritization software tool. Phase II, Prototype of a decision-support system / Committee on Identifying and Prioritizing New Preventive Vaccines for Development, Phase II, Board on Population Health and Public Health Practice, Board on Global Health ; Guruprasad Madhavan [and six others], editors ; Institute of Medicine of the National Academies.

Format:

Book

Contributor:

Madhavan, Guruprasad, editor.

Institute of Medicine (U.S.). Committee on Identifying and Prioritizing New Preventive Vaccines for Development, issuing body.

Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, issuing body.

Institute of Medicine (U.S.). Board on Global Health, issuing body.

Language:

English

Subjects (All):

Vaccines--Development--United States--Decision making.

Vaccines.

Vaccines industry--United States--Decision making.

Vaccines industry.

Resource allocation--United States.

Resource allocation.

Resource allocation--United States--Software.

Physical Description:

1 online resource (161 p.)

Edition:

1st ed.

Place of Publication:

Washington, District of Columbia : The National Academies Press, [2013]

Language Note:

English

Summary:

SMART Vaccines-Strategic Multi-Attribute Ranking Tool for Vaccines-is a prioritization software tool developed by the Institute of Medicine that utilizes decision science and modeling to help inform choices among candidates for new vaccine development. A blueprint for this computer-based guide was presented in the 2012 report Ranking Vaccines: A Prioritization Framework: Phase I . Ranking Vaccines: A Prioritization Software Tool,Phase II extends the proof-of-concept presented in the Phase I report, which was based on multi-attribute utility theory. This report refines a beta version of the model developed in the Phase I report and presents its next iteration, SMART Vaccines 1.0. Ranking Vaccines: Phase II discusses the methods underlying the development, validation, and evaluation of SMART Vaccines 1.0. It also discusses how SMART Vaccines should-and, just as importantly, should not-be used. The report also offers ideas for future enhancements for SMART Vaccines as well as for ideas for expanded uses and considerations and possibilities for the future.

Contents:

""Front Matter""; ""Reviewers""; ""Foreword""; ""Preface""; ""Contents""; ""Disclaimer""; ""Summary""; ""1 Introduction: New Vaccines and SMART Vaccines""; ""2 Refinements to the SMART Vaccines Model""; ""3 Data Synthesis, Software Redesign, and Evaluation""; ""4 Observations and Looking Forward""; ""References""; ""Appendix A: Computational Modeling for SMART Vaccines""; ""Appendix B: Candidate Disease Profiles""; ""Appendix C: Data Sources and Methodology for SMART Vaccines""; ""Appendix D: Verification and Analyses of the SMART Vaccines Computational Model""

""Appendix E: Stakeholder Speakers""""Appendix F: Biographical Information""

Notes:

Description based upon print version of record.

Includes bibliographical references.

Description based on print version record.

ISBN:

9780309266413

0309266416

9780309266390

0309266394

OCLC:

863088236